Phase II trial of dabrafenib and trametinib in patients with BRAFV600E/R or non-BRAFV600 mutated advanced solid tumors: Results from the BELIEVE trial (NCCH1901).

Tahara, M; Shimoi, T; Nishiwaki, S; Tanaka, S; Baba, E; Muto, M; Kinoshita, I; Sakai, D; Tabata, M; Hayashi, H; Ishioka, C; Mamesaya, N; Yamamoto, N

JOURNAL OF CLINICAL ONCOLOGY   Vol. 41 ( 16 )   2023.6

High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph plus ALL TKI-SCT Study

Nishiwaki, S; Sugiura, I; Fujisawa, S; Hatta, Y; Atsuta, Y; Doki, N; Kurahashi, S; Ueda, Y; Dobashi, N; Maeda, T; Taniguchi, Y; Tanaka, M; Kako, S; Ichinohe, T; Fukuda, T; Ohtake, S; Ishikawa, Y; Kiyoi, H; Matsumura, I; Miyazaki, Y

HEMASPHERE   Vol. 7 ( 6 ) page： e899   2023.6

Autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia is safe but poses challenges for long-term maintenance of molecular remission: Results of the Auto-Ph17 study

Nishiwaki, S; Sugiura, I; Sato, T; Kobayashi, M; Osaki, M; Sawa, M; Adachi, Y; Okabe, M; Saito, S; Morishita, T; Kohno, A; Nishiyama, T; Iida, H; Kurahashi, S; Kuwatsuka, Y; Sugiyama, D; Ito, S; Nishikawa, H; Kiyoi, H

EJHAEM   Vol. 4 ( 2 ) page： 358 - 369   2023.5

Poor Prognostic Combination of Additional Chromosomal Abnormalities in Ph plus ALL : JALSG Ph plus ALL TKI- SCT Study

Nishiwaki, S; Sugiura, I; Fujisawa, S; Hatta, Y; Doki, N; Kurahashi, S; Ueda, Y; Dobashi, N; Maeda, T; Taniguchi, Y; Tanaka, M; Kako, S; Ichinohe, T; Fukuda, T; Atsuta, Y; Ohtake, S; Ishikawa, Y; Kiyoi, H; Matsumura, I; Miyazaki, Y

BLOOD   Vol. 140   page： 6030 - 6032   2022.11

Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades

Nishiwaki, S; Akahoshi, Y; Morita-Fujita, M; Shimizu, H; Uchida, N; Ozawa, Y; Fukuda, T; Tanaka, M; Ikegame, K; Ota, S; Katayama, Y; Takahashi, S; Kawakita, T; Ara, T; Onizuka, M; Kimura, T; Tanaka, J; Atsuta, Y; Arai, Y

BLOOD ADVANCES   Vol. 6 ( 15 ) page： 4558 - 4569   2022.8

Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

Sugiura, I; Doki, N; Hata, T; Cho, R; Ito, T; Suehiro, Y; Tanaka, M; Kako, S; Matsuda, M; Yokoyama, H; Ishikawa, Y; Taniguchi, Y; Hagihara, M; Ozawa, Y; Ueda, Y; Hirano, D; Sakura, T; Tsuji, M; Kamae, T; Fujita, H; Hiramoto, N; Onoda, M; Fujisawa, S; Hatta, Y; Dobashi, N; Nishiwaki, S; Atsuta, Y; Kobayashi, Y; Hayakawa, F; Ohtake, S; Naoe, T; Miyazaki, Y

BLOOD ADVANCES   Vol. 6 ( 2 ) page： 624 - 636   2022.1

COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global Perspective

Nishiwaki, S; Ando, Y

FRONTIERS IN MEDICINE   Vol. 8   page： 812370   2021.12

The differential effect of disease status at allogeneic hematopoietic cell transplantation on outcomes in acute myeloid and lymphoblastic leukemia

Yanada, M; Konuma, T; Yamasaki, S; Mizuno, S; Hirabayashi, S; Nishiwaki, S; Uchida, N; Doki, N; Tanaka, M; Ozawa, Y; Sawa, M; Eto, T; Kawakita, T; Ota, S; Fukuda, T; Onizuka, M; Kimura, T; Atsuta, Y; Kako, S; Yano, S

ANNALS OF HEMATOLOGY   Vol. 100 ( 12 ) page： 3017 - 3027   2021.12

Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation-a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCT

Akahoshi, Y; Arai, Y; Nishiwaki, S; Tachibana, T; Shinohara, A; Doki, N; Uchida, N; Tanaka, M; Kanda, Y; Shiratori, S; Ozawa, Y; Shono, K; Katayama, Y; Tanaka, J; Fukuda, T; Atsuta, Y; Kako, S

BONE MARROW TRANSPLANTATION   Vol. 56 ( 11 ) page： 2842 - 2848   2021.11

Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy

Kako, S; Hayakawa, F; Imai, K; Tanaka, J; Mizuta, S; Nishiwaki, S; Kanamori, H; Mukae, J; Ozawa, Y; Kondo, T; Fukuda, T; Ichinohe, T; Ota, S; Tanaka, Y; Murayama, T; Kurahashi, S; Sakura, T; Usui, N; Ohtake, S; Kiyoi, H; Matsumura, I; Miyazaki, Y; Atsuta, Y

INTERNATIONAL JOURNAL OF HEMATOLOGY   Vol. 114 ( 5 ) page： 608 - 619   2021.11

Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia

Akahoshi, Y; Arai, Y; Nishiwaki, S; Mizuta, S; Marumo, A; Uchida, N; Kanda, Y; Sakai, H; Takada, S; Fukuda, T; Fujisawa, S; Ashida, T; Tanaka, J; Atsuta, Y; Kako, S

INTERNATIONAL JOURNAL OF HEMATOLOGY   Vol. 113 ( 6 ) page： 832 - 839   2021.6

Phase I clinical trial of intra-bone marrow cotransplantation of mesenchymal stem cells in cord blood transplantation

Goto, T; Murata, M; Nishida, T; Terakura, S; Kamoshita, S; Ishikawa, Y; Ushijima, Y; Adachi, Y; Suzuki, S; Kato, K; Hirakawa, A; Nishiwaki, S; Nishio, N; Takahashi, Y; Kodera, Y; Matsushita, T; Kiyoi, H

STEM CELLS TRANSLATIONAL MEDICINE   Vol. 10 ( 4 ) page： 542 - 553   2021.4

Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia

Nishiwaki, S; Sugiura, I; Koyama, D; Ozawa, Y; Osaki, M; Ishikawa, Y; Kiyoi, H

BIOMARKER RESEARCH   Vol. 9 ( 1 ) page： 13   2021.2

Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph<SUP>+</SUP> ALL during both CR1 and CR2

Nishiwaki, S; Akahoshi, Y; Mizuta, S; Shinohara, A; Hirabayashi, S; Noguchi, Y; Fukuda, T; Uchida, N; Tanaka, M; Onizuka, M; Ozawa, Y; Ota, S; Shiratori, S; Onishi, Y; Kanda, Y; Sawa, M; Tanaka, J; Atsuta, Y; Kako, S

BLOOD ADVANCES   Vol. 5 ( 2 ) page： 584 - 592   2021.1

<i>In vivo</i> tracking of transplanted macrophages with near infrared fluorescent dye reveals temporal distribution and specific homing in the liver that can be perturbed by clodronate liposomes

Nishiwaki, S; Saito, S; Takeshita, K; Kato, H; Ueda, R; Takami, A; Naoe, T; Ogawa, M; Nakayama, T

PLOS ONE   Vol. 15 ( 12 ) page： e0242488   2020.12

Multi-Lineage <i>BCR-ABL</i> Expression in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Associated With Improved Prognosis but No Specific Molecular Features

Nishiwaki, S; Kim, JH; Ito, M; Maeda, M; Okuno, Y; Koyama, D; Ozawa, Y; Gunji, M; Osaki, M; Kitamura, K; Ushijima, Y; Ishikawa, Y; Miyamura, K; Sugiura, I; Kiyoi, H

FRONTIERS IN ONCOLOGY   Vol. 10   page： 586567   2020.10

Gap between pediatric and adult approvals of molecular targeted drugs

Nishiwaki, S; Ando, Y

SCIENTIFIC REPORTS   Vol. 10 ( 1 ) page： 17145   2020.10

Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT

Akahoshi, Y; Nishiwaki, S; Arai, Y; Harada, K; Najima, Y; Kanda, Y; Shono, K; Ota, S; Fukuda, T; Uchida, N; Shiratori, S; Tanaka, M; Tanaka, J; Atsuta, Y; Kako, S

BONE MARROW TRANSPLANTATION   Vol. 55 ( 7 ) page： 1317 - 1325   2020.7

A consideration for efficient unrelated hematopoietic stem cell source acquisition-from an experience of Japan

Nishiwaki, S; Miyamura, K; Kanda, Y; Takanashi, M; Uchida, N; Fukuda, T; Ikegame, K; Ohashi, K; Eto, T; Ozawa, Y; Shiratori, S; Iwato, K; Matsuoka, K; Hidaka, M; Ichinohe, T; Atsuta, Y; Kodera, Y; Okamoto, S

BONE MARROW TRANSPLANTATION   Vol. 55 ( 3 ) page： 657 - 660   2020.3

Myeloablative Vs Reduced-Intensity Conditioning for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Among Patients over 50 Years Old Who Achieved Negative Minimal Residual Disease

Akahoshi, Y; Nishiwaki, S; Arai, Y; Harada, K; Doki, N; Kanda, Y; Shono, K; Ohta, S; Fukuda, T; Uchida, N; Tanakaw, J; Atsuta, Y; Kako, S

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION   Vol. 26 ( 3 ) page： S162 - S163   2020.3

Phase I Study of Cord Blood Transplantation with Intra-Bone Marrow Injection of Mesenchymal Stem Cells

Goto, T; Murata, M; Nishida, T; Terakura, S; Kamoshita, S; Ishikawa, Y; Ushijima, Y; Adachi, Y; Kato, K; Hirakawa, A; Nishiwaki, S; Nishio, N; Takahashi, Y; Kodera, Y; Matsushita, T; Kiyoi, H

BLOOD   Vol. 134   2019.11

Dasatinib-Based Two-Step Induction Prior to Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the JALSG Ph+ALL213 Study

Sugiura, I; Doki, N; Hata, T; Cho, R; Ito, T; Suehiro, Y; Kanamori, H; Kako, S; Matsuda, M; Yokoyama, H; Taniguchi, Y; Hagihara, M; Ozawa, Y; Fujisawa, S; Dobashi, N; Hatta, Y; Asada, N; Ohashi, K; Onishi, Y; Shiro, K; Nishiwaki, S; Atsuta, Y; Hayakawa, F; Ohtake, S; Miyazaki, Y

BLOOD   Vol. 134   2019.11

The Optimal Treatment Strategy for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission in the Era of High-Intensity Chemotherapy

Kako, S; Hayakawa, F; Imai, K; Tanaka, J; Mizuta, S; Nishiwaki, S; Kanamori, H; Doki, N; Uchida, N; Ikegame, K; Fukuda, T; Ichinohe, T; Ota, S; Tanaka, Y; Murayama, T; Kurahashi, S; Sakura, T; Usui, N; Ohtake, S; Kiyoi, H; Matsumura, I; Miyazaki, Y; Atsuta, Y

BLOOD   Vol. 134   2019.11

Application of the New Process for Unapproved Drug Use: Dilemma of Universal Health Care Coverage in Japan

Nishiwaki, S; Ando, Y

JOURNAL OF GLOBAL ONCOLOGY   Vol. 5   page： 1 - 3   2019.11

Different impact of BCR-ABL transcripts on allogeneic hematopoietic cell transplantation from different graft sources for Ph plus ALL with minimal residual disease

Nishiwaki, S; Mizuta, S; Ohashi, K; Fukuda, T; Uchida, N; Tachibana, T; Onizuka, M; Ozawa, Y; Onishi, Y; Takahashi, S; Eto, T; Nakamae, H; Tanaka, J; Ichinohe, T; Atsuta, Y; Kako, S

AMERICAN JOURNAL OF HEMATOLOGY   Vol. 94 ( 11 ) page： E301 - E305   2019.11

Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia

Akahoshi, Y; Nishiwaki, S; Mizuta, S; Ohashi, K; Uchida, N; Tanaka, M; Fukuda, T; Ozawa, Y; Takahashi, S; Onizuka, M; Shiratori, S; Nakamae, H; Kanda, Y; Ichinohe, T; Atsuta, Y; Kako, S

CANCER SCIENCE   Vol. 110 ( 10 ) page： 3255 - 3266   2019.10

Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Adolescents and Young Adults

Hangai, M; Urayama, KY; Tanaka, J; Kato, K; Nishiwaki, S; Koh, K; Noguchi, M; Kato, K; Yoshida, N; Sato, M; Goto, H; Yuza, Y; Hashii, Y; Atsuta, Y; Mizuta, S; Kato, M

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION   Vol. 25 ( 8 ) page： 1597 - 1602   2019.8

Prophylactic Use of Tyrosine Kinase Inhibitors in Patients with Negative Results for Minimal Residual Disease after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Akahoshi, Y; Nishiwaki, S; Mizuta, S; Ohashi, K; Uchida, N; Kanamori, H; Fukuda, T; Ozawa, Y; Kanda, Y; Ichinohe, T; Atsuta, Y; Kako, S

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION   Vol. 25 ( 3 )   2019.3

Availability of HLA-allele-matched unrelated donors: estimation from haplotype frequency in the Japanese population.

Nishiwaki S, Tanaka H, Kojima H, Okamoto S

Bone marrow transplantation   Vol. 54 ( 2 ) page： 300 - 303   2019.2

Optimal Interval for Detection of Molecular Relapse after Stop of TKI in Ph plus ALL Calculating By M Kinetics

Miyamura, K; Nishiwaki, S

BLOOD   Vol. 132   2018.11

Outcomes of strategic alternative donor selection or suspending donor search based on Japan Marrow Donor Program coordination status

Kawashima Naomi, Nishiwaki Satoshi, Shimizu Naoko, Kamoshita Sonoko, Watakabe Kyoko, Yokohata Emi, Kurahashi Shingo, Ozawa Yukiyasu, Miyamura Koichi

INTERNATIONAL JOURNAL OF HEMATOLOGY   Vol. 107 ( 5 ) page： 551 - 558   2018.5

Phase I study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells: A clinical study protocol

Goto, T; Murata, M; Terakura, S; Nishida, T; Adachi, Y; Ushijima, Y; Shimada, K; Ishikawa, Y; Hayakawa, F; Nishio, N; Nishiwaki, S; Hirakawa, A; Kato, K; Takahashi, Y; Kiyoi, H

MEDICINE   Vol. 97 ( 17 ) page： e0449   2018.4

Efficacy and safety of autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: A study protocol for a multicenter exploratory prospective study (Auto-Ph17 study) Reviewed

Nishiwaki S, Sugiura I, Miyata Y, Saito S, Sawa M, Nishida T, Miyamura K, Kuwatsuka Y, Kohno A, Yuge M, Kasai M, Iida H, Kurahashi S, Osaki M, Goto T, Terakura S, Murata M, Nishikawa H, Kiyoi H

Medicine   Vol. 96 ( 52 ) page： e9568   2017.12

Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 BCR-ABL-positive acute myeloid leukaemia: A case report and literature review Reviewed

Harada Y, Nishiwaki S, Sugimoto T, Onodera K, Goto T, Sato T, Kamoshita S, Kawashima N, Seto A, Okuno S, Yamamoto S, Iwasaki T, Ozawa Y, Miyamura K, Akatsuka Y, Sugiura I

Medicine   Vol. 96 ( 50 ) page： e9160   2017.12

Impact of Synchronous Multiple Primary Malignant Tumors on Newly Diagnosed Hematological Malignancies Reviewed

Nishiwaki S, Okuno S, Suzuki K, Kurahashi S, Sugiura I

Clinical Lymphoma, Myeloma & Leukemia   Vol. 17 ( 12 ) page： E79 - E85   2017.12

Efficacy and safety of autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: A study protocol for a multicenter exploratory prospective study (Auto-Ph17 study)

Nishiwaki, S; Sugiura, I; Miyata, Y; Saito, S; Sawa, M; Nishida, T; Miyamura, K; Kuwatsuka, Y; Kohno, A; Yuge, M; Kasai, M; Iida, H; Kurahashi, S; Osaki, M; Goto, T; Terakura, S; Murata, M; Nishikawa, H; Kiyoi, H

MEDICINE   Vol. 96 ( 52 ) page： e9568   2017.12

Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 <i>BCR</i>-<i>ABL</i>-positive acute myeloid leukaemia A case report and literature review

Harada, Y; Nishiwaki, S; Sugimoto, T; Onodera, K; Goto, T; Sato, T; Kamoshita, S; Kawashima, N; Seto, A; Okuno, S; Yamamoto, S; Iwasaki, T; Ozawa, Y; Miyamura, K; Akatsuka, Y; Sugiura, I

MEDICINE   Vol. 96 ( 50 ) page： e9160   2017.12

Prognostic impact of synchronous multiple primary malignant tumors on newly diagnosed hematological malignancies

Nishiwaki, S; Okuno, S; Suzuki, K; Kurahashi, S; Sugiura, I

ANNALS OF ONCOLOGY   Vol. 28   2017.11

Effective chemomobilization with etoposide and cytarabine (EC regimen) in lymphoma patients: a single-center, retrospective, observational study.

Koyama D, Nishiwaki S, Harada Y, Yamamoto S, Kurahashi S, Sugimoto T, Iwasaki T, Sugiura I

Japanese journal of clinical oncology   Vol. 47 ( 9 ) page： 820 - 825   2017.9

Effective chemomobilization with etoposide and cytarabine (EC regimen) in lymphoma patients: a single-center, retrospective, observational study Reviewed

Koyama D, Nishiwaki S, Harada Y, Yamamoto S, Kurahashi S, Sugimoto T, Iwasaki T, Sugiura I

Japanese Journal of Clinical Oncology   Vol. 47 ( 9 ) page： 820-825   2017.9

Increase of bone marrow macrophages and CD8<SUP>+</SUP> T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation

Kawashima, N; Terakura, S; Nishiwaki, S; Koyama, D; Ozawa, Y; Ito, M; Miyamura, K

BONE MARROW TRANSPLANTATION   Vol. 52 ( 8 ) page： 1164 - 1170   2017.8

PROGNOSTIC IMPACT OF SYNCHRONOUS MULTIPLE PRIMARY MALIGNANT TUMORS ON NEWLY DIAGNOSED LYMPHOMA PATIENTS

Nishiwaki, S; Okuno, S; Suzuki, K; Kurahashi, S; Sugiura, I

HAEMATOLOGICA   Vol. 102   page： 700 - 700   2017.6

Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients

Nishiwaki, S; Maeda, M; Yamada, M; Okuno, S; Harada, Y; Suzuki, K; Kurahashi, S; Urano, F; Okamura, S; Sugiura, I

BLOOD   Vol. 129 ( 1 ) page： 126 - 128   2017.1

Clinical efficacy of fecal occult blood test followed by colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients Reviewed

Nishiwaki S, Maeda M, Yamada M, Okuno S, Harada Y, Suzuki K, Kurahashi S, Urano F, Okamura S, Sugiura I

Blood   Vol. 129 ( 1 ) page： 126-128   2017.1

A new prognostic index to make short-term prognosis in MDS patients treated with azacitidine; a combination of p53 expression and cytogenetics Reviewed

Nishiwaki S, Ito M, Watarai R, Okuno S, Harada Y, Yamamoto S, Suzuki K, Kurahashi S, Iwasaki T, Sugiura I

Leukemia Research   Vol. 41   page： 21-6   2016

Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the Adult ALL WG of the JSHCT Reviewed

Nishiwaki S, Imai K, Mizuta S, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Takahashi S, Uchida N, Eto T, Nakamae H, Yujiri T, Mori S, Nagamura-Inoue T, Suzuki R, Atsuta Y, Tanaka J

Bone Marrow Transplant   Vol. 51 ( 1 ) page： 43-55   2016

Rules of providing cord blood for iPS cells for research Reviewed

Nishiwaki S

Cytotherapy   Vol. 17 ( 7 ) page： 1008   2015

Cervical epidural hematoma in a healthy donor presenting stroke mimic symptoms: a rare adverse event following peripheral blood stem cell apheresis Reviewed

Terabe S, Nishiwaki S, Koyama D, Okuno S, Harada Y, Tomita H, Yoshihara H, Iwasaki T, Sugiura I

Japanese Journal of Clinical Oncology   Vol. 45 ( 6 ) page： 584-7   2015

Roles of volunteers and professionals in medical development -insights from the development of Allo-HSCT Reviewed

Nishiwaki S

Japanese Journal of Clinical Oncology   Vol. 45 ( 5 ) page： 502-3   2015

Pros and Cons of Legislation on Allogeneic Hematopoietic Stem Cell Transplantation Reviewed

Nishiwaki S

Japanese Journal of Clinical Oncology   Vol. 45 ( 3 ) page： 311-2   2015

Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL-positive acute lymphoblastic leukemia Reviewed

Mizuta S, Matsuo K, Nishiwaki S, Imai K, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Miyamura K, Takahashi S, Onizuka M, Atsuta Y, Suzuki R, Morishima Y, Kato K, Sakamaki H, Tanaka J

Blood   Vol. 123 ( 15 ) page： 2325-32   2014

Complete nationwide survey on umbilical cord blood freezing bag breakage in Japan Reviewed

Nishiwaki S, Izumi J

Cytotherapy   Vol. 16 ( 11 ) page： 1590-4   2014

Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functions Reviewed

Nishiwaki S, Nakayama T, Murata M, Nishida T, Terakura S, Saito S, Kato T, Mizuno H, Imahashi N, Seto A, Ozawa Y, Miyamura K, Ito M, Takeshita K, Kato H, Toyokuni D, Nagao K, Ueda R, Naoe T

PLoS One   Vol. 9 ( 5 ) page： e96252   2014

Provision of human immunodeficiency virus infection following cord blood transplantation Reviewed

Nishiwaki S

British Journal of Haematology   Vol. 166 ( 6 ) page： 956-7   2014

Impact of donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation Reviewed

Nishiwaki S, Miyamura K, Ohashi K, Kurokawa M, Taniguchi S, Fukuda T, Ikegame K, Takahashi S, Mori T, Imai K, Iida H, Hidaka M, Sakamaki H, Morisima Y, Kato K, Suzuki R, Tanaka J

Annals of Oncology   Vol. 24 ( 6 ) page： 1594-602   2013

Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative acute lymphoblastic leukemia: What should we choose when no HLA-matched related donor is available? Invited Reviewed

Nishiwaki S, Atsuta Y, Tanaka J

Bone Marrow Transplantation   Vol. 48 ( 11 ) page： 1369-76   2013

Allogeneic stem cell transplant for adult Philadelphia chromosome-negative acute lymphoblastic leukemia Reviewed

Nishiwaki S, Miyamura K

Leukemia & Lymphoma   Vol. 53 ( 4 ) page： 550-6   2012

Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis Reviewed

Nishiwaki S, Nakayama T, Saito S, Mizuno H, Ozaki T, Takahashi Y, Maruyama S, Nishida T, Murata M, Kojima S,Naoe T

International Journal of Hematology   Vol. 96 ( 3 ) page： 295-300   2012

Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation: macrophage-targeted steroid therapy Reviewed

Nishiwaki S, Nakayama T, Murata M, Nishida T, Sugimoto K, Saito S, Kato T, Mizuno H, Imahashi N, Seto A, Ozawa Y, Goto T, Koyama D, Yokohata E, Kubota N, Kamoshita S, Miyamura K, Matsumoto K, Ito M, Naoe T

International Journal of Hematology   Vol. 95 ( 4 ) page： 428-33   2012

Reduced-intensity versus conventional myeloablative conditioning for patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in complete remission Reviewed

Nishiwaki S, Inamoto Y, Imamura M, Tsurumi H, Hatanaka K, Kawa K, Suzuki R, Miyamura K

Blood   Vol. 117 ( 13 ) page： 3698-9   2011

Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission Reviewed

Nishiwaki S, Inamoto Y, Sakamaki H, Kurokawa M, Iida H, Ogawa H, Fukuda T, Ozawa Y, Kobayashi N, Kasai M, Mori T, Iwato K, Yoshida T, Onizuka M, Kawa K, Morisima Y, Suzuki R, Atsuta Y, Miyamura K

Blood   Vol. 116 ( 20 ) page： 4368-75   2010

Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission Reviewed

Nishiwaki S, Terakura S, Yasuda T, Imahashi N, Sao H, Iida H, Kamiya Y, Niimi K, Morishita Y, Kohno A, Yokozawa T, Ohashi H, Sawa M, Kodera Y, Miyamura K

International Journal of Hematology   Vol. 91 ( 3 ) page： 419-25   2010

Impact of Post-transplant Imatinib Administration on Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia Reviewed

Nishiwaki S, Miyamura K, Kato C, Terakura S, Ohashi K, Sakamaki H, Nakao S, Harigae H, Kodera Y

Anticancer Research   Vol. 30 ( 6 ) page： 2415-8   2010

Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease Reviewed

Nishiwaki S, Terakura S, Ito, M, Goto T, Seto A, Watanabe K, Yanagisawa M, Imanashi N, Tsukamoto S, Shimba M, Ozawa Y, Miyamura K

Blood   Vol. 114 ( 14 ) page： 3113-6   2009

Impact of the basal metabolic ratio in predicting early deaths after allogeneic stem cell transplantation Reviewed

Nishiwaki S, Miyamura K, Seto A, Watanabe K, Yanagisawa M, Imahashi N, Shimba M, Yasuda T, Kuwatsuka Y, Oba T, Terakura S, Kodera Y

American Journal of Hematology   Vol. 84 ( 9 ) page： 608-11   2009

血液内科・成人フィラデルフィア染色体陰性急性リンパ性白血病に対する同種造血幹細胞移植

西脇聡史（ Role： Sole author）

科学評論社  2011 

血液・腫瘍科・皮膚GVHDにおけるマクロファージ浸潤の臨床的意義：治療抵抗性GVHDの手がかりとなるか？

西脇聡史, 伊藤雅文（ Role： Joint author）

科学評論社  2010 

内科・微小残存病変の定量　－治療の道しるべとなるか?－

西脇聡史, 宮村耕一（ Role： Joint author）

南江堂  2007 

A new prognostic index to predict short-term prognosis in MDS patients treated with azacitidine; combination of p53 expression and cytogenetics International conference

Nishiwaki S, Ito M, Okuno S, Harada Y, Yamamoto S, Iwasaki T, Sugiura I

20th Congress of the European Hematology Association 

ダサチニブによる無症候性出血性腸炎に対する便潜血検査と下部消化管内視鏡検査の有用性

西脇聡史, 前多松喜, 山田雅弘, 奥野真吾, 原田靖彦, 鈴木弘太郎, 倉橋信悟, 浦野文博, 岡村正造, 杉浦勇

第78回日本血液学会　総会 

Ph(+)ALLにおけるMRDと移植成績 Invited

西脇聡史, 宮村耕一

第38回日本造血細胞移植学会総会